FindTrial
Sign In

A cohort study of the clinical efficacy of Calcium D in the treatment of bone loss in patients with COVID-19 Study protocol summary

A cohort study of the clinical efficacy of Calcium D in the treatment of bone loss in patients with COVID-19 Study protocol summary

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071875
Enrollment
Unknown
Registered
2023-05-26
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

Calcium D Group:take Calcium D
Control Group:None

Sponsors

Qilu Hospital of Shandong University(Qingdao)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. age 50 to 90 years. 2. confirmed diagnosis of neo-coronavirus infection based on nucleic acid results, clinical symptoms, signs and imaging manifestations. 3. meeting the diagnostic criteria for medium or heavy COVID-19

Exclusion criteria

Exclusion criteria: 1. patients with poor physical condition or poor compliance to cooperate in completing follow-up visits and examinations. 2. patients with mild or critically ill COVID-19. 3. pregnant or have a pregnancy planned during the study period. 4. participating in other studies that may have an impact on the results of this study.

Design outcomes

Primary

MeasureTime frame
CT values of the L1 vertebrae;Bone mass change rate;—

Countries

China

Contacts

Public ContactHaipeng Si

Qilu Hospital of Shandong University(Qingdao)

18560082571@163.com+86 185 6008 2571

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026